Folate-PEG modified poly(2-(2-aminoethoxy)ethoxy)phosphazene/DNA nanoparticles for gene delivery: Synthesis, preparation and in vitro transfection efficiency

International Journal of Pharmaceutics

Volumn 392, Issue 1-2, 2010, Pages 241-248

  Zhang, Pengcheng ^a   Zhang, Zhiwen ^a   Yang, Yongxin ^a   Li, Yaping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

DNA; Folic acid; Gene; Nanoparticles; Poly(phosphazene)

Indexed keywords

DNA NANOPARTICLE; DRUG CARRIER; FOLATE RECEPTOR; FOLIC ACID; MACROGOL; PLASMID DNA; POLY[2 (2 AMINOETHOXY)ETHOXY]PHOSPHAZENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CHEMICAL MODIFICATION; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; DRUG UPTAKE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; SYNTHESIS; ZETA POTENTIAL;

ANIMALS; CARRIER PROTEINS; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; DNA; DRUG CARRIERS; FOLIC ACID; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; MOLECULAR STRUCTURE; NANOPARTICLES; ORGANOPHOSPHORUS COMPOUNDS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RECEPTORS, CELL SURFACE; TRANSFECTION;

EID: 77952744733     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.030     Document Type: Article

References (35)

1. Allcock H.R., Chang J.Y. Poly(organophosphazenes) with oligopeptides as side groups-prospective biomaterials. Macromolecules 1991, 24:993-999.
2. Asayama S., Maruyama A., Cho C.S., Akaike T. Design of comb-type polyamine copolymers for a novel pH-sensitive DNA carrier. Bioconjugate Chem. 1997, 8:833-838.
3. Bergen J.M., Park I.K., Horner P.J., Pun S.H. Nonviral approaches for neuronal delivery of nucleic acids. Pharm. Res. 2008, 25:983-998.
4. Boussif O., Lezoualch F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonuceotide transfer into cells in culture and in-vivo: to polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7301-9297.
5. Chen W.N., Luo W.J., Wang S.G., Bei J.Z. Synthesis and properties of poly(l-lactide)-poly (ethylene glycol) multiblock copolymers by coupling triblock copolymers. Polym. Adv. Technol. 2003, 14:245-253.
6. De Wolf H.K., Luten J., Snel C.J., Oussoren C., Hennink W.E., Storm G. In vivo tumor transfection mediated by polyplexes based on biodegradable poly(DMAEA)-phosphazene. J. Control. Release 2005, 109:275-287.
7. De Wolf H.K., de Raad M., Snel C., van Steenbergen M.J., Fens M.H.A.M., Storm G., Hennink W.E. Biodegradable poly(2-dimethylamino ethylamino)phosphazene for in vivo gene delivery to tumor cells. Effect of polymer molecular weight. Pharm. Res. 2007, 24:1572-1580.
8. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 2008, 5:487-495.
9. El-Aneed A. An overview of current delivery systems in cancer gene therapy. J. Control. Release 2004, 94:1-14.
10. Erbacher P., Bettinger T., Belguise-Valladier P., Zou S.M., Coll J.L., Behr J.P., Remy J.S. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. 1999, 1:210-222.
11. Kawakami S., Higuchi Y., Hashida M. Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J. Pharm. Sci. 2008, 97:726-745.
12. Kamen B.A., Smith A.K. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv. Drug Deliv. Rev. 2004, 56:1085-1097.
13. Kim D., Lee E.S., Park K., Kwon I.C., Bae Y.H. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. Pharm. Res. 2008, 25:2074-2082.
14. Kunath K., von Harpe A., Fischer D., Peterson H., Bickel U., Voigt K., Kissel T. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J. Control. Release 2003, 89:113-125.
15. Laurencin C.T., Koh H.J., Neenan T.X., Allcock H.R., Langer R. Controlled release using a new bioerodible polyphosphazene matrix system. J. Biomed. Mater. Res. Part A 1987, 21:1231-1246.
16. Leamon C.P., Low P.S. Membrane folate-binding proteins are responsible for folate protein conjugate endocytosis into cultured-cells. Biochem. J. 1993, 291:855-860.
17. Lu Y.J., Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 2002, 54:675-693.
18. Luten J., van Steenis J.H., van Someren R., Kemmink J., Schuurmans-Nieuwenbroek N.M.E., Koning G.A., Crommelin D.J.A., van Nostrum C.F., Hennink W.E. Water-soluble biodegradable cationic polyphosphazenes for gene delivery. J. Control. Release 2003, 89:483-497.
19. Luten J., van Steenbergen M.J., Lok M.C., de Graaff A.M., van Nostrum C.F., Talsma H., Hennink W.E. Degradable PEG-folate coated poly(DMAEA-co-BA)phosphazene-based polyplexes exhibit receptor-specific gene expression. Eur. J. Pharm. Sci. 2008, 33:241-251.
20. Maxfield F.R., McGraw T.E. Endocytic recycling. Nat. Rev. Mol. Cell Biol. 2004, 5:121-132.
21. Mok H., Bae K.H., Ahn C.H., Park T.G. PEGylated and MMP-2 specifically DePEGylated quantum dots: comparative evaluation of cellular uptake. Langmuir 2009, 25:1645-1650.
22. Nayak S., Lee H., Chmielewski J., Lyon L.A. Folate-mediated cell targeting and cytotoxicity using thermoresponsive microgels. J. Am. Chem. Soc. 2004, 126:10258-10259.
23. Paranjpe P.V., Chen Y., Kholodovych V., Welsh W., Stein S., Sinka P.J. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation. J. Control. Release 2004, 100:275-292.
24. Park T.G., Jeong J.H., Kim S.W. Current status of polymeric gene delivery systems. Adv. Drug Deliv. Rev. 2006, 58:467-486.
25. Qiu L.Y., Bae Y.H. Self-assembled polyethylenimine-graft-poly(epsilon-caprolactone) micelles as potential dual carriers of genes and anticancer drugs. Biomaterials 2007, 28:4132-4142.
26. Rolland A. Gene medicines: the end of the beginning?. Adv. Drug Deliv. Rev. 2005, 57:669-673.
27. Rosenholm J.M., Meinander A., Peulhu E., Niemi R., Eriksson J.E., Sahlgren C., Linden M. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 2009, 3:197-206.
28. Rui Y.J., Wang S., Low P.S., Thompson D.H. Diplasmenylcholine-folate liposomes: an efficient vehicle for intracellular drug delivery. J. Am. Chem. Soc. 1998, 120:11213-11218.
29. Russ V., Wagner E. Cell and tissue targeting of nucleic acids for cancer gene therapy. Pharm. Res. 2007, 24:1047-1057.
30. Stevens P.J., Sekido M., Lee R.J. A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm. Res. 2004, 21:2153-2157.
31. Van de watering P., Cherng J.Y., Talsma H., Hennink W.E. Relation between transfection efficiency and cytotoxicity of poly(2-(dimethylamino)ethyl methacrylate)/plasmid nanoparticles. J. Control. Release 1997, 49:59-69.
32. Weber N., Ortega P., Clemente M.I., Shcharbin D., Bryszewska M., de la Mata F.J., Gomez R., Munoz-Fernandez M.A. Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes. J. Control. Release 2008, 132:55-64.
33. Yang Y.X., Xu Z.H., Jiang J.G., Gao Y., Gu W.W., Chen L.L., Tang X.Z., Li Y.P. Poly(imidazole/DMAEA)phosphazene/DNA self-assembled nanoparticles for gene delivery: synthesis and in vitro transfection. J. Control. Release 2008, 127:273-279.
34. Yang Y.X., Xu Z.H., Chen S.W., Gao Y., Gu W.W., Chen L.L., Pei Y.Y., Li Y.P. Histidylated cationic polyorganophosphazene/DNA self-assembled nanoparticles for gene delivery. Int. J. Pharm. 2008, 353:277-282.
35. Zahr A.S., Davis C.A., Pishko M.V. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 2006, 22:8178-8185.